TRIPLE-NEGATIVE BREAST CARCINOMA
Clinical trials for TRIPLE-NEGATIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new TRIPLE-NEGATIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for TRIPLE-NEGATIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted combo tested for tough breast cancer
Disease control TerminatedThis study tested whether adding a targeted drug called alpelisib to a chemotherapy drug (nab-paclitaxel) could help shrink tumors before surgery. It was for people with a specific, hard-to-treat type of breast cancer (triple-negative) that had not responded well to a common firs…
Matched conditions: TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug tested to fight back against stubborn breast cancer
Disease control TerminatedThis study tested if a drug called abemaciclib could help control a hard-to-treat type of breast cancer that did not fully respond to standard chemotherapy. It involved 26 women whose cancer could still be surgically removed. The goal was to see if taking the drug for a short per…
Matched conditions: TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC